BioVie Inc. (BIVI) is priced at $37.92 after the most recent trading session. At the very opening of the session, the stock price was $32.10 and reached a high price of $39.9499, prior to closing the session it reached the value of $29.94. The stock touched a low price of $31.6201.
Recently in News on October 30, 2020, BioVie Interview to Air on Bloomberg International on the RedChip Money Report. BioVie Inc. (NASDAQ: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for liver disease, today announced an interview with Terren Peizer, Chairman and Chief Executive Officer, will air on The RedChip Money Report television program this Sunday November 1st. The RedChip Money Report airs in 100 million homes on Sundays at 6 p.m. local time in every country in Europe on Bloomberg International. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
BioVie Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $39.95 on 01/15/21, with the lowest value was $15.25 for the same time period, recorded on 01/04/21.
BioVie Inc. (BIVI) full year performance was 574.13%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BioVie Inc. shares are logging 9.79% during the 52-week period from high price, and 1623.64% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.20 and $34.54.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 279739 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the BioVie Inc. (BIVI) recorded performance in the market was 118.94%, having the revenues showcasing 268.51% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 416.74M, as it employees total of 2 workers.
Specialists analysis on BioVie Inc. (BIVI)
During the last month, 0 analysts gave the BioVie Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 13.08, with a change in the price was noted +13.92. In a similar fashion, BioVie Inc. posted a movement of +58.00% for the period of last 100 days, recording 49,564 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BIVI is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
Trends and Technical analysis: BioVie Inc. (BIVI)
Raw Stochastic average of BioVie Inc. in the period of last 50 days is set at 93.74%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 92.64%. In the last 20 days, the company’s Stochastic %K was 90.36% and its Stochastic %D was recorded 88.91%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 118.94%. Additionally, trading for the stock in the period of the last six months notably improved by 203.36%, alongside a boost of 574.13% for the period of the last 12 months. The shares increased approximately by 55.16% in the 7-day charts and went down by 187.49% in the period of the last 30 days. Common stock shares were driven by 268.51% during last recorded quarter.